HLS Therapeutics Inc.
HLTRF
$2.96
-$0.33-10.03%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.02M | -4.84M | -5.68M | -6.11M | -5.40M |
| Total Depreciation and Amortization | 5.43M | 5.51M | 5.86M | 5.92M | 7.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 799.00K | 835.00K | 1.50M | 664.00K | 1.00M |
| Change in Net Operating Assets | -5.00K | 2.00K | 843.00K | 301.00K | 1.09M |
| Cash from Operations | 3.21M | 1.50M | 2.52M | 778.00K | 3.73M |
| Capital Expenditure | -13.00K | 0.00 | 0.00 | -2.00K | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -1.50M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 13.25M | -- | 0.00 |
| Cash from Investing | -13.00K | -1.50M | 13.25M | -2.00K | -14.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.65M | -15.10M | -1.61M | -2.22M | -3.31M |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | 0.00 | 0.00 | -317.00K | -283.00K | -580.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | 0.00 |
| Other Financing Activities | 0.00 | 0.00 | -658.00K | -533.00K | 0.00 |
| Cash from Financing | -2.65M | -15.10M | -2.58M | -3.03M | -3.89M |
| Foreign Exchange rate Adjustments | -622.00K | 120.00K | -117.00K | -251.00K | 310.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.00K | -14.98M | 13.07M | -2.51M | 144.00K |